The global Sleep Apnea Devices market size is estimated to surpass around US$ 7.1 billion by 2030 and is expected to grow at a CAGR of 6.8% during forecast period 2021 to 2030.
The global Sleep Apnea Devices market size is estimated to surpass around US$ 7.1 billion by 2030 and is expected to grow at a CAGR of 6.8% during forecast period 2021 to 2030.
Growth Factors
The global prevalence of obesity is estimated to reach 18.0% in men and 21.0% in women by 2025. This, in turn, is estimated to drive the market as more than half of the overweight or obese people suffer from Obstructive Sleep Apnea (OSA).
Moreover, the rising geriatric population due to increasing life expectancy is expected to impel the prevalence of OSA. Sleep disorders increase with age, which is one of the key factors for high market share. However, low awareness and consequent low penetration of sleep apnea equipment in developing and underdeveloped economies present lucrative growth opportunities to market participants.
Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/37522
The outbreak of COVID-19 pandemic negatively impacted the growth of the medical equipment required to diagnose the disease. There was the temporary closure of physician practices, home medical equipment suppliers, and sleep clinics due to quarantine or government restrictions, to control the spread of COVID-19. This, in turn, has resulted in the decreased growth rate of diagnostic equipment during the COVID-19 related lockdowns.
However, sleep and respiratory care equipment witnessed a rapid increase in demand during the pandemic. The usage of PAP devices as an alternative to ventilators significantly increased the demand for PAP equipment. Moreover, a rise in adherence to PAP therapy for sleep apnea after the initial stages of the pandemic, as risk factors associated with COVID-19 are commonly present in the patients, positively impacted market growth.
The development of new technologies for the treatment and diagnosis of the disease is driving market growth. Moreover, new alternatives to CPAP equipment such as nasal and oral equipment are developed for patients with low CPAP tolerance. For instance, In February 2021, GoPAPFree, a homecare oral devices manufacturer for OSA, launched O2 Vent Optima to serve as an effective and more convenient CPAP alternative. This device increases sleep apnea therapy response by 40.0%. In February 2020, Fisher and Paykel launched F&P Evora with CapFit headgear, a compact nasal mask for treating sleep apnea. The company launched this product in the markets of New Zealand, Europe, Australia, and Canada.
Report Highlights
The therapeutic devices segment dominated the market and held the highest revenue share of 79.6% in 2020. Therapeutic devices include, oral devices, nasal devices, and chin straps. Increasing awareness about these diseases, the rising availability of technologically advanced devices, the growing number of initiatives by local governments, and adherence to supporting treatment by patients are factors expected to provide lucrative opportunities for SA device manufacturers. This, in turn, is expected to drive the growth of the therapeutic devices segment over the forecast period.
However, the sleep apnea masks segment is expected to grow fast over the forecast period. The adoption of SA masks is increasing owing to the growing prevalence of SA comorbidities and the increasing adoption of CPAP machines for disease management. Technological advancements in SA devices are anticipated to drive the adoption of SA masks. For instance, in 2019, ResMed launched AirFit N30i, its first top-of-head-connected nasal CPAP mask, across the U.S. with a newly designed nasal cradle cushion that sits just under the wearer’s nose.
North America dominated the sleep apnea devices market and accounted for the highest revenue share of 49.0%. The rising prevalence of respiratory disorders is leading to some or other form of sleeping disorder, which is driving the market. In addition, growing awareness about sleep apnea, a large patient pool, and the presence of international manufacturers are factors anticipated to strengthen the market share of this region. For instance, key players such as ResMed, Philips Respironics, and Somnetics International, Inc. have established a strong presence in the region and have also established strong distribution channels for easy supply of their products. Moreover, the number of therapeutic tests conducted in the region for confirming the presence of sleep apnea is rapidly rising, as many people are concerned about the health risks arising out of this condition.
However, in Asia Pacific, the market is anticipated to witness a significant growth rate during the forecast period. The rising geriatric population and increasing prevalence of lifestyle diseases are among the key factors driving the Asia Pacific market. For instance, according to the WHO, chronic respiratory diseases, diabetes, cardiovascular diseases, and cancer are some of the major conditions leading to the highest deaths in the region.
In addition, as per the IDF Diabetes Atlas 9th Edition, around 87.6 million people in the age group of 20 to 79 years suffer from diabetes in the South East Asia region. Such a rising prevalence of chronic conditions is expected to increase the adoption of sleep apnea devices in the region. As per a PubMed article, the prevalence of obstructive sleep apnea in Asia in middle-aged individuals ranges from 4.1% to 7.5% in males and 2.1% to 3.2% in females. As per an Asian Pacific Society of Respirology article, in May 2020, the prevalence in APAC countries ranged from 7.8% in Hong Kong to 77.2% in Malaysia, for mild sleep apnea cases. The research study highlighted names of four Asian countries among the top 10, with the highest prevalence of OSA. The countries with prevalence estimates for OSA with AHI > 15 events/hour were China (66 million patients, with a prevalence of 8.8%) and India (29 million, 5.4%).
Key Players
- ResMed
- Phillips Respironics
- Fisher & Paykel Healthcare Limited
- Curative Medical, Inc.
- Invacare Corporation
- Somnetics International, Inc.
- BMC Medical Co., Ltd.
- Natus Medical Incorporated
- SOMNOmedics GmbH
- Compumedics Limited
- Itamar Medical Ltd.
- Nihon Kohden Corporation
Market Segmentation
- Product Type Outlook
- Diagnostic Devices
- Actigraphs
- Polysomnography (PSG) device
- Respiratory Polygraphs
- Cardiologists
- ENT Specialists
- Homecare Nurses
- Sleep Physicians
- Pulmonologists
- Primary Care Physicians/General Physicians
- Others
- Pulse Oximeters
- Therapeutic Devices
- Positive Airway Pressure (PAP) Devices
- CPAP
- APAP
- Bi-PAP
- Oral Devices
- Nasal Devices
- Chin Straps
- Positive Airway Pressure (PAP) Devices
- Sleep Apnea Masks
- Diagnostic Devices
- Regional Outlook
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Click Here to View Full Report Table of Contents
Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/37522
You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333